Parkinsons Library

Parkinson’s disease and stem cells.

150 150 NZ Stem Cell Treatment Centre

2011 Jan; 1812(1) : 1-11. Epub 2010 Aug 14. Stem cell potential in Parkinson’s disease and molecular factors for the generation of dopamine neurons. Kim HJ. Abstract Parkinson’s disease (PD) involves the loss of dopamine (DA) neurons, making it the most expected neurodegenerative disease to be treated by cell replacement therapy. Stem cells are a…

read more

Implications for cell based therapies in Parkinson’s.

150 150 NZ Stem Cell Treatment Centre

Biol Blood Marrow Transplant. 2010 Nov; 16(11) : 1530-40. Epub 2010 Jun 10. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cellbased therapies in Parkinson’s disease. Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. Institute of Science, Clinica Alemana Universidad del Desarrollo, Santiago, Chile. Abstract It is thought that…

read more

Ageing and neurodegenerative diseases.

150 150 NZ Stem Cell Treatment Centre

Ageing Res Rev. 2010 Nov; 9 Suppl 1 : S36-46. Epub 2010 Aug 21. Ageing and neurodegenerative diseases. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Department of Neurology, Zhongxiao Branch, Taipei City Hospital/No 87, Tongde Rd, Nangang Dist, Taipei City 115, Taiwan. Abstract Ageing, which all creatures must encounter, is a challenge…

read more

Delivery of neurotrophins to the Parkinsonian rat brain.

150 150 NZ Stem Cell Treatment Centre

Brain Res. 2010 Nov 4; 1359 : 33-43. Epub 2010 Aug 21. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain. Moloney TC, Rooney GE, Barry FP, Howard L, Dowd E. The Department of Pharmacology & Therapeutics, National University of Ireland, Galway, Ireland; National Centre…

read more

Parkinson’s disease in a rat model.

150 150 NZ Stem Cell Treatment Centre

Neurochem Res. 2010 Oct; 35(10) : 1522-9. Epub 2010 Jul 24. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson’s disease. Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.…

read more

Stem cells and neurological diseases.

150 150 NZ Stem Cell Treatment Centre

Gene Ther. 2010 Sep 30. [Epub ahead of print] Progress and prospects: stem cells and neurological diseases. Gögel S, Gubernator M, Minger SL. Wolfson Centre for Age-Related Diseases, Guy’s Campus, King’s College London, London, UK. Abstract The central nervous system has limited capacity of regenerating lost tissue in slowly progressive, degenerative neurological conditions such as…

read more

Dopaminergic neuronal cells in Parkinson’s model rats.

150 150 NZ Stem Cell Treatment Centre

Neurosurg. 2010 Sep; 113(3) : 648-55. Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats. Higashida T, Jitsuki S, Kubo A, Mitsushima D, Kamiya Y, Kanno H. Department of Neurosurgery, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan. tets018@gmail.com Abstract OBJECT: In the authors’ previous study, they observed…

read more

Stem cells promote recovery in a rat model of Parkinson’s disease.

150 150 NZ Stem Cell Treatment Centre

J Neurosci Res. 2010 Sep; 88(12) : 2669-81. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson’s disease. Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC. Department of Pediatrics, Neurobiology Program, Children’s Memorial Research Center, Feinberg School of Medicine,…

read more

Translation of stem cell therapy for neurological diseases.

150 150 NZ Stem Cell Treatment Centre

Transl Res. 2010 Sep; 156(3) : 155-60. Epub 2010 Jul 23. Translation of stem cell therapy for neurological diseases. Schwarz SC, Schwarz J. Department of Neurology, University of Leipzig, Leipzig, Germany. Abstract “Regenerative medicine” hopefully will provide novel therapies for diseases that remain without effective therapy. This development is also true for most neurodegenerative disorders…

read more

Cerebral Transplantation and Parkinson’s Disease Rats.

150 150 NZ Stem Cell Treatment Centre

Appl Biochem Biotechnol. 2010 Sep 5. [Epub ahead of print] In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson’s Disease Rats Using Magnetic Resonance Imaging. Guo J, Shen JK, Wang L, Xiao L, Zhang RJ, Luo WF, Gong ZG, Sun J, Xu H, Sirois P, Li K. Department of Radiology,…

read more